Genetic Variability of AdeRS Two-Component System Associated with Tigecycline Resistance in XDR-Acinetobacter baumannii Isolates
- 299 Downloads
The emergence of tigecycline resistance has increased in the last years. Although tigecycline-resistant Acinetobacter baumannii isolates were described all over the world, few reports regarding the molecular basis of this resistance are available. It has been recognized that the overexpression of AdeABC efflux pump is related to the tigecycline-resistant phenotype. In 37 clinical A. baumannii isolates we first determined the tigecycline-resistant phenotype and then, within a selected group, we analyzed the sequence of the adeRS operon, which is involved in the expression of the AdeABC efflux pump. Nucleotide sequence analysis of adeR and adeS showed the presence of 5 and 16 alleles, respectively. These results expose a high genetic variability in both genes, the adeS gene being more susceptible to genetic variation. The presence of 2 AdeR and 2 AdeS new variants were reported. Two of the new AdeRS variants were present in the intermediate and the resistant tigecycline A. baumannii isolates, suggesting a putative role in the development of the observed phenotype. More studies need to be addressed to determine the role of the genetic variability observed in the adeRS operon.
KeywordsColistin Tigecycline Acinetobacter Baumannii Amino Acid Variation Agar Dilution Method
This study was supported by Grants PIP 11420100100152 to MSR and PICT 0120 to MSR, Buenos Aires, Argentina.
MS.R., and D.C are members of the career investigator of CONICET, Argentina. E.V and G.M.T have a Doctoral Fellowship from CONICET.
- 4.Deng M, Zhu MH, Li JJ, Bi S, Sheng ZK, Hu FS, Zhang JJ, Chen W, Xue XW, Sheng JF, Li LJ (2014) Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital. Antimicrob Agents Chemother 58(1):297–303. doi: 10.1128/AAC.01727-13 PubMedCentralPubMedCrossRefGoogle Scholar
- 5.De Pascale G, Montini L, Pennisi M, Bernini V, Maviglia R, Bello G, Spanu T, Tumbarello M, Antonelli M (2014) High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria. Crit Care 18(3):R90. doi: 10.1186/cc13858 PubMedCentralPubMedCrossRefGoogle Scholar
- 6.Dinc G, Demiraslan H, Elmali F, Ahmed SS, Metan G, Alp E, Doganay M (2013) Efficacy of sulbactam and its combination with imipenem, colistin and tigecycline in an experimental model of carbapenem-resistant Acinetobacter baumannii sepsis. Chemotherapy 59(5):325–329. doi: 10.1159/000356755 PubMedCrossRefGoogle Scholar
- 10.Higgins PG, Schneiders T, Hamprecht A, Seifert H (2010) In vivo selection of a missense mutation in adeR and conversion of the novel blaOXA-164 gene into blaOXA-58 in carbapenem-resistant Acinetobacter baumannii isolates from a hospitalized patient. Antimicrob Agents Chemother 54(12):5021–5027. doi: 10.1128/AAC.00598-10 PubMedCentralPubMedCrossRefGoogle Scholar
- 13.Liao CH, Kung HC, Hsu GJ, Lu PL, Liu YC, Chen CM, Lee CM, Sun W, Jang TN, Chiang PC, Cheng YJ, Lin HC, Shi ZY, Wang LS, Chuang YC, Tsao SM, Lu CT, Liu JW, Huang CH, Hsueh PR (2008) In-vitro activity of tigecycline against clinical isolates of Acinetobacter baumannii in Taiwan determined by the broth microdilution and disk diffusion methods. Int J Antimicrob Agents 32(Suppl 3):S192–S196. doi: 10.1016/S0924-8579(08)70027-X PubMedCrossRefGoogle Scholar
- 14.Liu JW, Jang TN, Cheng YJ, Hsu GJ, Sun W, Lu CT, Hsueh PR (2010) Comparison of the Etest and broth microdilution method for tigecycline susceptibility testing against clinical isolates of Acinetobacter baumannii from Taiwan. Int J Antimicrob Agents 35(2):201–202. doi: 10.1016/j.ijantimicag.2009.09.019 PubMedCrossRefGoogle Scholar
- 15.Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268–281. doi: 10.1111/j.1469-0691.2011.03570.x PubMedCrossRefGoogle Scholar
- 16.Marchand I, Damier-Piolle L, Courvalin P, Lambert T (2004) Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob Agents Chemother 48(9):3298–3304. doi: 10.1128/AAC.48.9.3298-3304.2004 PubMedCentralPubMedCrossRefGoogle Scholar
- 18.Stietz MS, Ramirez MS, Vilacoba E, Merkier AK, Limansky AS, Centron D, Catalano M (2013) Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect Genet Evol 14:294–301. doi: 10.1016/j.meegid.2012.12.020 PubMedCrossRefGoogle Scholar
- 19.Sun JR, Chan MC, Chang TY, Wang WY, Chiueh TS (2010) Overexpression of the adeB gene in clinical isolates of tigecycline-nonsusceptible Acinetobacter baumannii without insertion mutations in adeRS. Antimicrob Agents Chemother 54(11):4934–4938. doi: 10.1128/AAC.00414-10 PubMedCentralPubMedCrossRefGoogle Scholar
- 20.Traglia GM, Almuzara M, Merkier AK, Papalia M, Galanternik L, Radice M, Vay C, Centron D, Ramirez MS (2013) Distribution of allelic variants of the chromosomal gene bla OXA-114-like in Achromobacter xylosoxidans clinical isolates. Curr Microbiol 67(5):596–600. doi: 10.1007/s00284-013-0407-5 PubMedCrossRefGoogle Scholar